ArticleJTO clinical and research reports2024

Cabozantinib Response in a Patient With NSCLC Harboring Both MET Exon 14 Skipping Mutation and Secondary RET Fusion: A Case Report.

Carlos Torrado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.